[Psychosomatic disorders and Lexotanil (Ro 5-3350)].
作者信息
Bonard E C
出版信息
Rev Med Suisse Romande. 1975 Feb;95(2):95-104.
PMID:241111
Abstract
摘要
相似文献
1
[Psychosomatic disorders and Lexotanil (Ro 5-3350)].
Rev Med Suisse Romande. 1975 Feb;95(2):95-104.
2
[Action of the bromazepam-propantheline combination in patients with organic and functional gastrointestinal disorders].
Clin Ter. 1977 Nov 15;83(3):301-11.
3
[The association of lexotan + propantheline in the treatment of functional gastrointestinal disorders. Controlled clinical study].
Arch Sci Med (Torino). 1980 Jul-Sep;137(3):461-6.
4
Trazodone and psychosomatic medicine.曲唑酮与心身医学。
Curr Ther Res Clin Exp. 1973 Oct;15(10):789-98.
5
[Anatomical, functional, clinical and therapeutic aspects of syndromes involving urogenital spasm and pain].
Minerva Urol. 1979 Jan-Mar;31(1):39-52.
6
[Bromazepam in the treatment of somatized psychogenic disorders (author's transl)].
Wien Klin Wochenschr. 1979 Mar 30;91(7):240-4.
7
[Treatment of psychovegetative syndromes with bromazepam in an outpatient clinic].
Ther Umsch. 1977 Oct;34(10):701-7.
8
[Clinical trial of bromazepam in internal medicine. Double-blind cross-over comparison with placebo].
Clin Ter. 1975 Dec 31;75(6):603-10.
9
[A new anxiolytic: Lexotanil (Ro 5-3350)].
Rev Med Suisse Romande. 1975 Jun;95(6):479-87.
10
[Therapy of psychoautonomic disorders. Clinical double-blind duplex study with dipotassium chlorazepate and bromazepam].
MMW Munch Med Wochenschr. 1983 Jul 22;125(32-33):715-7.
Zotero 插件